cannabis hope drug firm prescription cannabis drug make uk biotech firm gw pharmaceutical set approve canada drug use treat central nervous system alleviate symptom multiple sclerosis m week ago share gw pharma lose third value uk regulator say wanted evidence drug benefit canadian authority say sativex drug consider approval approximately people canada diagnose ms people suffer condition uk many patient already smoke cannabis relieve symptom gw pharma sativex mouth spray could legally available m sufferer canada within next month first time drug approve anywhere world represent landmark gw pharma patient ms final approval canada little formality analyst say company expect full approval sativex early delighted receive qualify notice health canada look forward receive regulatory approval sativex canada early part say gw pharma executive chairman dr geoffrey guy uk government grant gw pharma licence grow cannabis plant medical research purpose satifex consist cannabis extract contain tetrahydrocannabinol cannabidiol cocktail also prove effective treating patient arthritis thousand plant grown secret location somewhere english countryside despite hope regulatory approval last year series delay put back sativex launch uk late news send share gw pharma